John Paulson Holdings 13F: Latest Paulson & Co Portfolio Changes
Paulson & Co. Famous for the greatest trade ever (2008 subprime). John Paulson became a billionaire by using credit default swaps to short the US housing market before the 2008 financial crisis, a trade chronicled in the book 'The Greatest Trade Ever'.
As of the latest Q2 2026 13F filing, John Paulson (managing Paulson & Co) reported a public portfolio value of $2.6B with 8 positions. This page tracks latest holdings, latest 13F changes, top buys, top sells, and top holdings from the public filing. The top recent buy was THM. The top recent sell was MDGL.
Open interactive portfolioLatest 13F portfolio changes
John Paulson holdings 13F summary: the latest Paulson & Co portfolio changes show top holdings including MADRIGAL PHARMACEUTICALS, PERPETUA RESOURCES, ACADIAN ASSET MANAGEMENT, BAUSCH HEALTH COS, and INTERNATIONAL TOWER HILL MIN, reported top buys such as INTERNATIONAL TOWER HILL MIN and Alphabet, and top sells or reductions such as MADRIGAL PHARMACEUTICALS, ACADIAN ASSET MANAGEMENT, AGNICO EAGLE MINES, and AMICUS THERAPEUTIC.
Latest filing metadata: quarter Q2 2026; report date 2026-06-30; filing date 2026-08-14; disclosure source SEC 13F.
John Paulson 13F portfolio and latest holdings overview
John Paulson's Q2 2026 13F holdings show Paulson & Co reporting 8 positions with a disclosed portfolio value of $2.6B. For readers searching John Paulson 13F holdings, John Paulson portfolio, Paulson & Co holdings, or latest 13F changes, the latest top holdings include MADRIGAL PHARMACEUTICALS, PERPETUA RESOURCES, ACADIAN ASSET MANAGEMENT, BAUSCH HEALTH COS, and INTERNATIONAL TOWER HILL MIN.
The three largest reported positions add up to roughly 70.2%, which helps readers judge portfolio concentration rather than just headline AUM. The largest reported sector exposure is Health Care at 42.0% of the disclosed portfolio. This makes the page useful for comparing the manager's actual disclosed exposure with market narratives around the same names.
The latest change data highlights reported buys such as INTERNATIONAL TOWER HILL MIN and Alphabet and reported reductions or exits such as MADRIGAL PHARMACEUTICALS, ACADIAN ASSET MANAGEMENT, AGNICO EAGLE MINES, and AMICUS THERAPEUTIC. Those changes should be read as historical disclosure signals, not as real-time trade alerts.
The filing metadata lists report date 2026-06-30, filing date 2026-08-14, SEC accession 0001013594-26-000913. SEC 13F reports are normally published up to 45 days after quarter end, so the data is best used to understand institutional positioning after the fact rather than to infer today's exact portfolio.
John Paulson portfolio analytics
the top five positions account for 92.3% of disclosed value; the largest sector exposure is Health Care at 42.0%; reported buy and sell activity implies roughly 58.5% turnover this period; cost-basis P&L across 8 tracked positions averages 174.4% (5/7 currently in profit).
Top reported holdings
| Holding | Reported value | Weight | Quarter change |
|---|---|---|---|
| MDGL whale holders MADRIGAL PHARMACEUTICALS INC | $719.5M | 27.9% | Reduced |
| PPTA whale holders PERPETUA RESOURCES CORP | $671.5M | 26.1% | Held |
| AAMI whale holders ACADIAN ASSET MANAGEMENT INC | $417.9M | 16.2% | Reduced |
| BHC whale holders BAUSCH HEALTH COS INC | $361.2M | 14.0% | Held |
| THM whale holders INTERNATIONAL TOWER HILL MIN | $207.9M | 8.1% | Increased |
| NG whale holders NOVAGOLD RESOURCES INC | $162.6M | 6.3% | Held |
| THRY whale holders THRYV HLDGS INC | $33.3M | 1.3% | Held |
| GOOGL whale holders ALPHABET INC | $1.8M | 0.1% | New |
Top buys
- THM whale holders — INTERNATIONAL TOWER HILL MIN ($207.9M)
- GOOGL whale holders — ALPHABET INC ($1.8M)
Top sells
- MDGL whale holders — MADRIGAL PHARMACEUTICALS INC ($719.5M)
- AAMI whale holders — ACADIAN ASSET MANAGEMENT INC ($417.9M)
- AEM whale holders — AGNICO EAGLE MINES LTD ($159.0M)
- FOLD whale holders — AMICUS THERAPEUTIC ($468.5K)
Allocation
- Health Care: 42.0%
- Energy: 32.4%
- Other: 25.6%
- Communication Services: 0.1%
Data notes
Report date: 2026-06-30
Disclosure source: SEC 13F
SEC 13F filings are delayed public disclosures and do not include every asset class, short positions, or real-time trades.
Related investor portfolios
- Robert Robotti 13F holdings and Robotti & Co portfolio changes — Robotti & Co
- HHLR Advisors 13F holdings and portfolio changes — HHLR Advisors
- PRIMECAP Management 13F holdings and PRIMECAP Management Company portfolio changes — PRIMECAP Management Company
- NPS Korea 13F holdings and National Pension Service portfolio changes — National Pension Service
- Tom Gayner 13F holdings and Markel Group portfolio changes — Markel Group
- Stephen Mandel 13F holdings and Lone Pine Capital portfolio changes — Lone Pine Capital
- Leon Cooperman 13F holdings and Omega Advisors portfolio changes — Omega Advisors
- Stanley Druckenmiller 13F holdings and Duquesne Family Office portfolio changes — Duquesne Family Office
Learn more in Whale Analyzer Academy
Learn more in Whale Analyzer Academy:
Frequently asked questions
John Paulson 13F Holdings
The Q2 2026 13F profile for John Paulson and Paulson & Co shows 8 reported positions, $2.6B in disclosed portfolio value, and top holdings including MADRIGAL PHARMACEUTICALS, PERPETUA RESOURCES, ACADIAN ASSET MANAGEMENT, BAUSCH HEALTH COS, and INTERNATIONAL TOWER HILL MIN.
What is John Paulson buying? Latest 13F changes
The latest tracked change data for John Paulson highlights reported buys such as INTERNATIONAL TOWER HILL MIN and Alphabet and reported sells or reductions such as MADRIGAL PHARMACEUTICALS, ACADIAN ASSET MANAGEMENT, AGNICO EAGLE MINES, and AMICUS THERAPEUTIC.
Paulson & Co top holdings
Paulson & Co top holdings are summarized from public disclosures with reported values, weights, portfolio concentration, top buys, top sells, and filing metadata where available.
John Paulson buys and sells
Use the top buys and top sells sections above to compare John Paulson's reported additions, reductions, exits, and latest portfolio activity against other tracked investors.
How delayed is John Paulson's 13F data?
SEC Form 13F requires institutional investment managers with $100M+ in US equities to disclose their holdings quarterly. Read our comprehensive 13F guide for timing, coverage, and limitations. Read the Whale Analyzer 13F guide.